Search
MBX Biosciences Inc
MBXAdd to Watchlist
55.805USD
+1.405+2.58%
Market hours 11/03, 09:32（ET）
2.69BMarket Cap
LossP/E TTM
MBX Analyst Recommendation Trends
In the current month, MBX has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MBX average Analyst price target in the last month is 96.556.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
4
4
4
4
4
4
4
4
7
7
8
7
7
7
6
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
11
11
12
11
12
12
11
11
Financial Forecasting
Based on analysts' estimates, MBX EPS is projected to reach -0.834 in FY2026Q3, following reported EPS of -0.778 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.61
-0.58
-0.63
-0.83
-0.95
Actual
-0.49
-0.50
-0.78
--
--
Surprise
+19.48%
+13.34%
-23.02%
--
--
FAQs
How have MBX Biosciences IncMBX's recent earnings per share performed?
The market expectation was USD -0.78, while MBX Biosciences IncMBX's earnings per share (EPS) for the previous quarter was USD -0.50. EPS for the next quarter is expected at USD -0.83.
What is the analyst rating for MBX Biosciences Inc?
Based on the ratings of MBX Biosciences Inc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.